Loading clinical trials...
Loading clinical trials...
Dose Finding Study of S-1, Oxaliplatin, and Irinotecan Combination Chemotherapy for Patients With Inoperable Advanced or Metastatic Gastrointestinal Cancers
Conditions
Interventions
OIS (Oxaliplatin, Irinotecan, S-1)
Locations
1
South Korea
Hallym University Medical Center
Anyang, South Korea
Start Date
June 1, 2012
Primary Completion Date
February 1, 2014
Completion Date
August 1, 2014
Last Updated
February 19, 2016
NCT06663319
NCT01750619
NCT06048146
NCT05551052
NCT07389525
NCT06301828
Lead Sponsor
Hallym University Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions